FIELD: medicine.
SUBSTANCE: for oestrogen β (ORβ) receptor analysis, single-cell suspensions of a tumour tissue and a reference culture which is a monolayer culture of MCF-7 line human breast cancer are prepared in solid tumours. The cells are fixed in 4 % formaldehyde, incubates with Tween 20, washed by means of phosphate buffer pH 7.4. Then they are incubated with primary and secondary antibodies, twice washed by means of phosphate buffer pH 7.4, and fluorescence is measured in a flow cytofluorimetre. The data are analysed by calculating the D value of a Kolmogorov-Smirnova statistical test. A percentage of specifically coloured cells is the D value multiplied by 100.
EFFECT: invention enables differential and strictly quantitative evaluation of ORβ expression in tumour tissue.
2 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR IMMUNOFLUORESCENCE ASSAY OF EXCISION REPAIR PROTEIN ERCC1 IN HUMAN SOLID TUMOURS | 2014 |
|
RU2563116C1 |
METHOD OF IMMUNOFLUORESCENT ANALYSIS OF MARKERS OF MULTIPLE MEDICATION RESISTANCE IN HUMAN SOLID TUMOURS | 2009 |
|
RU2413948C1 |
METHOD FOR MOLECULAR QUANTITATIVE DETECTION OF LOCAL PREVALENCE OF NON-SMALL CELL LUNG CANCER BY DOUBLE IMMUNOFLUORESCENT STAINING OF NORMAL AND TUMOUR TISSUE | 2020 |
|
RU2732973C1 |
METHOD FOR QUANTITATIVE ASSESSMENT OF CELL FRACTION IN EPITHELIAL-MESENCHYMAL PASSAGE IN ASCITIC FLUID AND SOLID TUMORS OF OVARIAN CANCER | 2018 |
|
RU2704814C1 |
METHOD FOR TUMOUR CELL DEATH INDUCTION | 2015 |
|
RU2620165C2 |
MONOMOLECULAR CHIMERIC T-CELL RECEPTOR TO CANCER ANTIGEN CA125 | 2018 |
|
RU2747095C2 |
METHOD FOR ESTIMATION OF TOTAL INDICATOR OF ANEUPLOIDY AND PROLIFERATIVE ACTIVITY OF TUMOUR CELLS OF NON-SMALL-CELL LUNG CANCER AND OVARIAN CANCER USING SPECIFIC DNA DYE DRAQ7 OF NEW GENERATION | 2016 |
|
RU2639251C1 |
CONJUGATES OF ANTIBODY-UREASE FOR THERAPEUTIC PURPOSES | 2016 |
|
RU2689689C2 |
METHOD FOR DETECTING TUMOUR CELLS CIRCULATING IN BLOOD BY MULTIPARAMETER FLOW CYTOMETRY | 2024 |
|
RU2825188C2 |
NOVEL PROTEIN STRUCTURES FOR DIAGNOSING AND THERAPY OF GD2-POSITIVE DISEASES | 2019 |
|
RU2708136C1 |
Authors
Dates
2011-09-20—Published
2010-07-27—Filed